A CDC study in 2017 found that depression affects about 1%-5% of the general elderly population, and that number rises significantly in elderly hospital patients (11.5%) and in those who require home healthcare (13.5%). The treatment of depression in the …

At the 63rd Annual Meeting of the American College of Neuropsychopharmacology, Rudolf Uher MUDr, PhD, spoke with Psychology Times about research being done at Dalhousie University testing biomarker-based selection of treatment. Patients with depression …

Relmada Therapeutics Inc. (Nasdaq: RLMD) will halt its Phase 3 studies of depression treatment REL-1017 following a data monitoring committee evaluation, sending the company searching for strategic alternatives. The late-stage biotechnology company will …

… for the development of its depression drug and explore strategic alternatives including … after the company said its depression drug, esmethadone, was “unlikely” to meet …

… 3 study test­ing its ma­jor de­pres­sion drug, REL-1017, is like­ly to …

… is betting could turn its depression drug flop into a success story … men and women respond to depression treatments.  “Females tend to respond better … -624 will perform against approved depression drugs, but it could provide a …

… said he has been prescribed depression medication and the harassment led to …

Source: Teona Swift / Pexels There are many signs of depression and they often manifest in different ways physically, emotionally, and cognitively. Medication for biological depression is ideally targeted to specific symptoms. Some medications focus …

… while enhancing serotonin signaling, while depression treatments might focus on strengthening both …